IpamorelinEvidence & Dosage
Selective GH releaser, cortisol‑sparing, and stack combinations.
Evidence at a glance
- Total studies
- 67
- With abstract
- 48
- Meta / Systematic / RCT
- 1
- Highly cited
- 33
- Publication years
- 1981–2026
Ipamorelin in the context of Peptides
This topic is part of our "Peptides" world. There you'll find methodology, evidence and the highest-impact levers — plus the order in which they sensibly build on each other.
Go to PeptidesTop studies on Ipamorelin
Ranked by influential-citation count and publication year.
Potent derivatives of glucagon-like peptide-1 with pharmacokinetic properties suitable for once daily administration.
Journal of medicinal chemistry2000128 influential citationsA series of very potent derivatives of the 30-amino acid peptide hormone glucagon-like peptide-1 (GLP-1) is described. The compounds were all derivatized with fatty acids in order to protract their action by facilitating binding to serum…
Conformational energy studies and in vitro and in vivo activity data on growth hormone-releasing peptides.
Endocrinology198461 influential citationsA series of growth hormone-releasing peptides have been designed and tested for both in vitro and in vivo activity. In vitro activity at 1-10 ng/ml was obtained for the pentapeptide, His-DTrp-Ala-Trp-DPhe-NH2 (I) and the hexapeptide,…
Ghrelin: An Emerging Therapy for Heart Failure
Clinical Endocrinology202555 influential citations<h4>Objective</h4>Ghrelin is emerging as a promising therapeutic option for heart failure (HF) due to its potent inotropic, anabolic, and cardioprotective properties. This review aims to critically examine the available clinical evidence…
Design, synthesis, and biological activity of peptides which release growth hormone in vitro.
Endocrinology198153 influential citationsExperimental observations showed that the analogs [D-Trp2]- and [D-Phe2]methionine enkephalin amide were weakly active in releasing GH from rat pituitary in vitro. These observations were used to design more active GH-releasing factors.…
Determination of growth hormone releasing peptides (GHRP) and their major metabolites in human urine for doping controls by means of liquid chromatography mass spectrometry.
Analytical and bioanalytical chemistry2011E33 influential citationsA family of small peptides has reached the focus of doping controls representing a comparably new strategy for cheating sportsmen. These growth hormone releasing peptides (GHRP) are orally active and induce an increased production of…
Simplifying and expanding the screening for peptides <2 kDa by direct urine injection, liquid chromatography, and ion mobility mass spectrometry.
Journal of separation science2016E23 influential citationsThe analysis of low-molecular-mass peptides in doping controls has become a mandatory aspect in sports drug testing and, thus, the number of samples that has to be tested for these analytes has been steadily increasing. Several peptides <2…
Determination of prohibited, small peptides in urine for sports drug testing by means of nano-liquid chromatography/benchtop quadrupole orbitrap tandem-mass spectrometry.
Journal of chromatography. A2012E21 influential citationsIn the present study, a screening assay was developed comprising 11 prohibited peptides (<1.5 kDa) that are sufficiently purified from urine using weak cation exchange with subsequent determination of all substances by means of nanoUHPLC…
A high-throughput LC-MS/MS screen for GHRP in equine and human urine, featuring peptide derivatization for improved chromatography.
Drug testing and analysis2014E21 influential citationsThe growth hormone releasing peptides (GHRPs) hexarelin, ipamorelin, alexamorelin, GHRP-1, GHRP-2, GHRP-4, GHRP-5, and GHRP-6 are all synthetic met-enkephalin analogues that include unnatural D-amino acids. They were designed specifically…
Determination of IGF-1 and IGF-2, their degradation products and synthetic analogues in urine by LC-MS/MS.
The Analyst201120 influential citationsPeptide analysis in doping controls by means of nano-UPLC coupled high resolution/high mass accuracy mass spectrometry provides the state-of-the-art technique in modern sports drug testing. The present study describes a recent application…
Metabolism of growth hormone releasing peptides.
Analytical chemistry2012E20 influential citationsNew, potentially performance enhancing compounds have frequently been introduced to licit and illicit markets and rapidly distributed via worldwide operating Internet platforms. Developing fast analytical strategies to follow these new…
Frequently asked
Are there safety considerations for Ipamorelin?
More topics in Peptides
Peptides Overview
Peptides, BPC-157, TB-500, safety and the state of the evidence.
Administration Routes
Subcutaneous, intramuscular, nasal, oral, topical — bioavailability and safety.
Autoimmunity Risk
Immune modulation can both promote tolerance and tip into dysregulation.
BPC-157
Peptide for tissue regeneration, healing, and athletic recovery.
Cerebrolysin
A pig-brain peptide mix, stroke studies, not approved in Germany.
CJC-1295
GHRH analog, half‑life variants and pulse patterns.
Dihexa
Angiotensin derivative, cognitive/neuroplasticity signals in animal models.
GHK-Cu
Copper peptide for skin health, anti-aging, and wound healing.
GHRP-2
GH releaser, older generation, appetite stimulation as a side effect.
GHRP-6
GH releaser with a strong appetite component.
GLP-1 Rebound
Weight regain after stopping without lifestyle anchors.
GLP-1 Side Effects
Nausea, gastric emptying, muscle loss, pancreatitis risk.
Hexarelin
GH releaser, fast tolerance build-up, cardiac signals.
IGF-1 LR3
Modified IGF-1 with a long half-life — hypertrophy, the cancer-risk debate.
Immune Modulation
Automatisch via Trend Scout entdeckt. Supplements targeting inflammation and immune resilience remain a central research area.. PubMed: 11956 Ergebnisse.
Injection Safety
Sterile technique, bacteriostatic water, skin disinfection — a medical topic.
KPV
An alpha-MSH fragment — anti-inflammatory, gut, skin, early research.
Liraglutide
First-generation GLP-1 for diabetes/obesity — daily, smaller effect size.
LL-37
Antimicrobial peptide, wound healing, immune modulation, early research.
MK-677
Ghrelin mimetic, not strictly a peptide — sleep, appetite, glucose risk.
Related topics from other worlds
Glycine
Glycine, sleep quality, body temperature and safety.
Magnesium for Sleep
Bisglycinate, threonate, and RCT studies on sleep outcomes.
Sleep Cycles
90-minute cycles — deep sleep early, REM later in the night.
Sleep Tracking
Wearables (Oura, Whoop) and HRV-sleep correlations.
Cardiovascular System
Blood pressure, heart rate, endothelium, cholesterol, cardiovascular risk factors.
Effect Size
p-value vs. practical relevance, Cohen's d, confidence intervals.